- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05906082
Vape-Free Text-Messaging: Pilot Study
August 3, 2025 updated by: Jovan Gwon, PhD, RN, FIAAN
Text-messaging E-cigarette Cessation Intervention for Young Adults in Rural Areas: A Pilot Study
This is a small pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of the e-cigarette cessation text-messaging intervention with young adults in rural areas.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53211
- Recruiting
- University of Wisconsin-Milwaukee
-
Contact:
- Seok Hyun Gwon, PhD, RN
- Phone Number: 4142296462
- Email: gwon@uwm.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- English speaking
- 18-24 years
- everyday e-cigarette use in the past month
- ownership of a mobile phone or smartphone with texting and internet access abilities
- knowledge of how to use text messages
- plan on quitting e-cigarette use within one month
- home address in a rural county of Wisconsin, Minnesota, North Dakota, and South Dakota
Exclusion Criteria:
- Individuals who reported use of other tobacco products (e.g., cigarettes, smokeless tobacco) than e-cigarettes in the past month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention (E-cigarette cessation text-messaging intervention)
|
This is the intervention for e-cigarette cessation using text messages targeting young adults in rural areas.
|
|
Active Comparator: Standard care (Standard care control using standard national resources)
This standard care group will receive standard care resources from smokefree.gov.
|
This is the standard care with national resources from smokefree.gov.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants recruited and randomized
Time Frame: Throughout 12 months
|
Number of participants recruited and randomized
|
Throughout 12 months
|
|
Self-reported proportion of text messages read
Time Frame: At 1 month
|
Proportion of text messages read during the intervention or standard care at 1 month
|
At 1 month
|
|
Retention rates (proportion of participants remained until 1 month post-intervention from enrollment)
Time Frame: At 1 month
|
Proportion of participants from enrollment to 1 month post-intervention or standard-care
|
At 1 month
|
|
Level of acceptability of the intervention
Time Frame: At 1 month
|
|
At 1 month
|
|
Proportion of salivary cotinine samples returned
Time Frame: At 1 month
|
Proportion of salivary cotinine samples returned to the office lab for cotinine analysis
|
At 1 month
|
|
Self-reported 7-days point prevalence abstinence from ENDS and other tobacco
Time Frame: At 1 month
|
Self-reported 7-days point prevalence abstinence from ENDS and other tobacco
|
At 1 month
|
|
Concentration of cotinine in saliva
Time Frame: At 1 month
|
Biochemically verified abstinence evaluated by salivary cotinine samples
|
At 1 month
|
|
Nicotine dependence (Penn State Electronic Cigarette Dependence Index)
Time Frame: At 1 month
|
Nicotine dependence (minimum 0 to maximum 20, higher scores mean a worse outcome.)
|
At 1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 25, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
May 26, 2023
First Submitted That Met QC Criteria
June 6, 2023
First Posted (Actual)
June 15, 2023
Study Record Updates
Last Update Posted (Actual)
August 7, 2025
Last Update Submitted That Met QC Criteria
August 3, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 23.179
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.